Skip to content
LexBuild

National Center for Advancing Translational Sciences; Notice of Closed Meeting

---
identifier: "/us/fr/2026-03461"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Center for Advancing Translational Sciences; Notice of Closed Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2026-03461"
section_name: "National Center for Advancing Translational Sciences; Notice of Closed Meeting"
positive_law: false
currency: "2026-02-23"
last_updated: "2026-02-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2026-03461"
document_type: "notice"
publication_date: "2026-02-23"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "91 FR 8496"
fr_volume: 91
---

#  National Center for Advancing Translational Sciences; Notice of Closed Meeting

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a  meeting of the National Center for Advancing Translational Sciences Advisory Council.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* National Center for Advancing Translational Sciences Advisory Council.

*Date:* March 24, 2026.

*Time:* 1:00 p.m. to 3:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Address:* National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Room 1E454, Rockville, MD 20850.

*Meeting Format:* Virtual Meeting.

*Contact Person:* Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Room 1E454, Rockville, MD 20850, (301) 435-0809, *[email protected].*

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

Dated: February 18, 2026.

Bruce A. George,

Program Analyst, Office of Federal Advisory Committee Policy.